(SGYP) |
0 (0%) 04-24 18:14 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
sell | buy |
Resistance 2: | 2.30 |
Resistance 1: | 1.97 |
Pivot price: | 1.77 |
Support 1: | 1.35 |
Support 2: | 0.97 |
52w High: | |
52w Low: |
EPS | 0.160 |
Book Value | 1.210 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | 1.48 |
Operating Margin (%) | 4.24 |
Return on Assets (ttm) | 7.0 |
Return on Equity (ttm) | 12.2 |
Sun, 21 Apr 2024
Karyopharm Therapeutics (KPTI) in Focus: Stock Goes Down 5.2% - Yahoo Movies Canada
Wed, 01 Dec 2021
OKYO Pharma Limited: Directorate Change - GlobeNewswire
Wed, 19 Dec 2018
End Of The Line For Synergy Pharmaceuticals (NASDAQ:SGYP-OLD-DEFUNCT-16944) - Seeking Alpha
Wed, 12 Dec 2018
Synergy Pharmaceuticals Bankruptcy: SGYP Stock Plummets on Filing - Yahoo Finance
Thu, 25 Oct 2018
Synergy Pharmaceuticals Provides Business Update - Business Wire
Thu, 25 Jan 2018
Synergy Pharmaceuticals Announces FDA Approval of TRULANCE® (Plecanatide) for the Treatment of Irritable Bowel ... - Business Wire
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |